Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age65+
SponsorUniversity of Limerick
About this trial
Prostate cancer is the most common solid tumour cancer amongst men in Ireland, with almost 4,000 new cases diagnosed annually and a median age at diagnosis of 67 years. The incidence of frailty amongst cancer patients is high. Among patients undergoing systemic anti-cancer therapy, frailty increases the risk of treatment related toxicity, hospitalisation, and death and is associated with a poorer quality of life.
This study aims to describe the demographic, clinical and frailty characteristics of men living with prostate cancer in the Mid-West of Ireland. In addition, we will assess the predictive accuracy of three frailty screening tools currently used in Irish clinical practice,G8, CFS and PRISMA 7, for predicting poorer outcomes at baseline, 6 and 12 months.
Eligibility criteria
Qualifiers
adults aged ≥65 years with a diagnosis of prostate cancer
Disqualifiers
Neither the patient nor the carer has sufficient proficiency in English sufficiently to complete consent or baseline assessment
Patients will be excluded if they present outside of research nurse (RN) operational hours( 8am and 5pm Monday - Friday).
Patients who are acutely unwell and unable to answer the questionnaire will also be excluded.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov